Scholarlink

Introduction <p>Studies have highlighted the important roles of circRNAs in various cancers. However, their specific functions in the lymph node metastasis (LNM) of colorectal cancer (CRC) remain largely unclear.</p> Methods <p>The Arraystar human circRNA microarray was used to identify circular RNAs (circRNAs) associated with LNM in colorectal cancer (CRC). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to measure circHELQ expression in CRC cell lines and tissue specimens. A series of in vitro and in vivo functional assays were subsequently conducted to investigate the role of circHELQ in LNM and CRC progression. Additionally, fluorescence in situ hybridization, dual-luciferase reporter assays, RNA pull-down, and Western blot experiments were carried out to elucidate the underlying regulatory mechanisms of circHELQ in CRC.</p> Results <p>Our results demonstrated that circHELQ expression was significantly upregulated in CRC and that its expression level was closely correlated with LNM. Gain- and loss-of-function experiments revealed that circHELQ promotes CRC progression and metastasis—including proliferation, migration, invasion, lymphatic vessel formation, and LNM—both in vitro and in vivo. Mechanistically, circHELQ acts as a competing endogenous RNA (ceRNA) that sponges miR-4793-3p, thereby alleviating its suppression of VEGFC. This circHELQ/miR-4793-3p/VEGFC axis drives LNM in CRC by upregulating VEGFC expression. Furthermore, we developed a cancer cell membrane–based siRNA delivery system (cMDS) targeting circHELQ, and these nanoparticles effectively suppressed CRC proliferation and LNM.</p> Conclusions <p>CircHELQ drives CRC progression and LNM and is a candidate prognostic biomarker. Furthermore, its molecular function renders it a viable target for nanoparticle-based therapeutic strategies against CRC.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lymph node metastasis-related circHELQ promotes progression and acts as a nanotherapeutic target in colorectal cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月8日

查看全文
  • Jingwen Peng,
  • Wen Song,
  • Mengzhen Lei,
  • Min-Er Zhong,
  • Ruijian Chen,
  • Yuwei Liu,
  • Haifeng Zhou,
  • Yifan Liu,
  • Zejian Lyu,
  • Junyuan Deng,
  • Jiatong Lin,
  • Qi Zhang,
  • Zihao Pan

摘要

Introduction

Studies have highlighted the important roles of circRNAs in various cancers. However, their specific functions in the lymph node metastasis (LNM) of colorectal cancer (CRC) remain largely unclear.

Methods

The Arraystar human circRNA microarray was used to identify circular RNAs (circRNAs) associated with LNM in colorectal cancer (CRC). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to measure circHELQ expression in CRC cell lines and tissue specimens. A series of in vitro and in vivo functional assays were subsequently conducted to investigate the role of circHELQ in LNM and CRC progression. Additionally, fluorescence in situ hybridization, dual-luciferase reporter assays, RNA pull-down, and Western blot experiments were carried out to elucidate the underlying regulatory mechanisms of circHELQ in CRC.

Results

Our results demonstrated that circHELQ expression was significantly upregulated in CRC and that its expression level was closely correlated with LNM. Gain- and loss-of-function experiments revealed that circHELQ promotes CRC progression and metastasis—including proliferation, migration, invasion, lymphatic vessel formation, and LNM—both in vitro and in vivo. Mechanistically, circHELQ acts as a competing endogenous RNA (ceRNA) that sponges miR-4793-3p, thereby alleviating its suppression of VEGFC. This circHELQ/miR-4793-3p/VEGFC axis drives LNM in CRC by upregulating VEGFC expression. Furthermore, we developed a cancer cell membrane–based siRNA delivery system (cMDS) targeting circHELQ, and these nanoparticles effectively suppressed CRC proliferation and LNM.

Conclusions

CircHELQ drives CRC progression and LNM and is a candidate prognostic biomarker. Furthermore, its molecular function renders it a viable target for nanoparticle-based therapeutic strategies against CRC.

Graphical abstract